latest news releases from the newsroom
Axfood's sales January-July 2002
STOCKHOLM, Sweden, Aug. 7, 2002 (PRIMEZONE) -- Consolidated net sales* (excluding VAT) for the month of July totalled SEK 2,803 m (2,726), an increase of 2.8% compared with the same period a year ago. For stores owned by the Group, the increase was 11.6% for the month.
Metso to Supply Pulp Bleaching System to Suzano Bahia Sul, Brazil
HELSINKI, Finland, Aug. 7, 2002 (PRIMEZONE) -- Metso Paper will supply a new pulp bleaching system to the Brazilian pulp and paper producer, Suzano Bahia Sul. The bleaching system will be installed at the company's Suzano mill in the state of Sao Paulo. The new line is scheduled to start up in November 2003. The value of Metso Paper's delivery, together with local supplies, is over EUR 20 million.
If P&C Insurance
If P&C: Invitation to Teleconference
STOCKHOLM, Sweden, Aug. 7, 2002 (PRIMEZONE) -- We are pleased to invite you to a conference call Tuesday August 13, 2002, at 14.00, Stockholm Time to review If P&C Insurance's Q2 Report Announcement. Torbjorn Magnusson, CEO, Ricard Wennerklint, CFO, and Nils Henriksson, CIO, will represent If. Prepared remarks will take approximately 20 minutes and will be followed by a question-and-answer session. The presentation will be published on Ifs IR web site, www.if- insurance.com.
Women First HealthCare, Inc.
Women First HealthCare Launches Synalgos DC painpak
SAN DIEGO, Aug. 7, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC), a specialty pharmaceutical company, today announced that it has launched its Synalgos(r) DC Capsules (drocode (dihydrocodeine) bitartrate, aspirin and caffeine) in a convenient blister package of 12 capsules that the Company is calling a "painpak." A total of 225 sales representatives will be detailing the product to the medical community. Synalgos(r) DC painpak will have a highly targeted and comprehensive promotional campaign supported by WFHC's own direct sales force, calling on OB/GYN's, and Professional Detailing, Inc. (PDI), a contract sales organization. This campaign will focus on physician specialties that prescribe C-III opiates for post procedural acute pain and inflammation. Women First acquired Synalgos(r) DC from Wyeth in November 2001.
SAS Group Management fully staffed, Gunilla Berg and John S. Dueholm New Members
STOCKHOLM, Sweden, Aug. 7, 2002 (PRIMEZONE) -- Two new members of the SAS Group Management were appointed at today's Board of Directors meeting. Gunilla Berg will be the new Chief Financial Officer of the SAS Group. John S. Dueholm will be responsible for the Airline Support and Airline Related Businesses area. Consequently, SAS Group management is fully staffed.
BMS Joins Other Pharma Investing in Biacore C for QC
UPPSALA, Sweden, Aug. 7, 2002 (PRIMEZONE) -- International AB today announced that Bristol-Myers Squibb (BMS) is the latest major pharmaceutical company to invest in its Biacore(R) C system for rapid concentration analysis in drug development, manufacturing quality control (QC) and in-process control applications. Biacore C is the first system based on Surface Plasmon Resonance technology designed specifically for compliance with worldwide regulatory requirements.